ArticleDrug and alcohol review2025
Creating Safer Injecting Practices Through Community-Led Harm Reduction: Lessons From People Who Use Steroids for the Alcohol and Other Drug Sector.
Article in Drug and alcohol review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- What anabolic-androgenic steroids reveal about the limits of current harm reduction models.Addiction (Abingdon, England) · 2026Article
- Co-producing a peer-led health conversation tool for the health services workforce to facilitate safer use of anabolic-androgenic steroids.Harm reduction journal · 2025Article
- Creating Safer Injecting Practices Through Community-Led Harm Reduction: Lessons From People Who Use Steroids for the Alcohol and Other Drug Sector.Drug and alcohol review · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionResearch on anabolic-androgenic steroid (AAS) use has addressed health outcomes, social dynamics, service access and risk management strategies. Yet little work has examined how these domains converge in injection practices, where community-led knowledge and structural barriers shape harm reduction. This study aimed to explore people's experiences of injecting AAS, focusing on practices, challenges and sources of harm reduction knowledge, and examined how consumers develop safer injection methods through lived-living expertise.
methodsData were drawn from semi-structured interviews with Australian AAS consumers (N = 25), including follow-ups with 15 participants, resulting in 40 research interactions. These interactions examined safer injecting, harm reduction strategies and structural barriers. Analysis employed iterative categorisation, integrating lived-living experience and a lens of prefigurative politics to develop knowledge into three theme-categories.
resultsParticipants articulated that injecting, when done correctly, was perceived as a safer usage pathway. However, many participants lacked access to clear, evidence-based injection guidance and acquired information through informal sources including online forums and peer networks. Some AAS consumers experienced bacterial infections and abscesses, highlighting the ongoing risks associated with injecting. Experienced consumers had developed practices, through experimentation, on site rotation, injection volume and hygiene to mitigate harms. DISCUSSION AND
conclusionsAAS consumers prefigure harm reduction through their community, yet informal learning is inconsistent. Peer-led interventions which partner with trusted allies, including clinicians and health workers, can work toward reducing injecting-related harms in the community; thus, moving the alcohol and other drug sector toward sustainable, collective care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.